{"altmetric_id":4418322,"counts":{"readers":{"mendeley":7,"citeulike":0,"connotea":0},"total":{"posts_count":8},"twitter":{"unique_users_count":7,"unique_users":["PECjournal","ConcordeMedica","uhesllc","HealthEconBot","mHealthReporter","MltplSclppr","zeneconomicss"],"posts_count":7},"facebook":{"unique_users_count":1,"unique_users":["588931371162191"],"posts_count":1}},"selected_quotes":["Playing around with non-healthcare costs"],"citation":{"altmetric_jid":"4f6fa5123cf058f6100032dc","authors":["Livio Garattini","Francesca Ghislandi","Milene Rangel Da Costa"],"doi":"10.1007\/s40273-015-0322-7","first_seen_on":"2015-08-20T20:09:48+00:00","funders":["niehs"],"issns":["1179-2027"],"journal":"PharmacoEconomics","last_mentioned_on":1440238357,"links":["http:\/\/link.springer.com\/article\/10.1007\/s40273-015-0322-7","http:\/\/link.springer.com\/article\/10.1007%2Fs40273-015-0322-7","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26293887?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter"],"pdf_url":"http:\/\/link.springer.com\/content\/pdf\/10.1007%2Fs40273-015-0322-7.pdf","pmid":"26293887","pubdate":"2015-08-21T00:00:00+00:00","publisher":"Springer International Publishing","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"},{"name":"Economics","scheme":"era"},{"name":"Health Administration","scheme":"springer"},{"name":"Health Economics","scheme":"springer"},{"name":"Medicine & Public Health","scheme":"springer"},{"name":"Pharmacoeconomics and Health Outcomes","scheme":"springer"},{"name":"Public Health","scheme":"springer"},{"name":"Quality of Life Research","scheme":"springer"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"subjects":["pharmacology","drugtherapy"],"title":"Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs?","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/costeffectiveness-modeling-multiple-sclerosis-playing-around-nonhealthcare-costs"},"altmetric_score":{"score":2.75,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.75},"context_for_score":{"all":{"total_number_of_other_articles":5570954,"mean":6.3320939207361,"rank":2060261,"this_scored_higher_than_pct":62,"this_scored_higher_than":3490917,"rank_type":"exact","sample_size":5570954,"percentile":62},"similar_age_3m":{"total_number_of_other_articles":192464,"mean":9.1906892441664,"rank":63746,"this_scored_higher_than_pct":66,"this_scored_higher_than":127617,"rank_type":"exact","sample_size":192464,"percentile":66},"this_journal":{"total_number_of_other_articles":676,"mean":3.1706014814815,"rank":260,"this_scored_higher_than_pct":60,"this_scored_higher_than":411,"rank_type":"exact","sample_size":676,"percentile":60},"similar_age_this_journal_3m":{"total_number_of_other_articles":13,"mean":3.0625,"rank":5,"this_scored_higher_than_pct":53,"this_scored_higher_than":7,"rank_type":"exact","sample_size":13,"percentile":53}}},"demographics":{"poster_types":{"member_of_the_public":6,"science_communicator":1},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":1,"Members of the public":6}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":1,"Other":3,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":4,"Economics, Econometrics and Finance":3}}},"geo":{"twitter":{"NZ":1,"GB":1,"US":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/PECjournal\/statuses\/634457259200786432","license":"gnip","citation_ids":[4418322],"posted_on":"2015-08-20T20:09:32+00:00","author":{"name":"Chris Carswell","url":"http:\/\/link.springer.com\/journal\/40273","image":"https:\/\/pbs.twimg.com\/profile_images\/1642449043\/IMG_0022_normal.JPG","description":"Editor in Chief PharmacoEconomics. Past President ISPOR NZ Chapter, runner and pianist. All views are my own","id_on_source":"PECjournal","tweeter_id":"105718980","geo":{"lt":-42,"ln":174,"country":"NZ"},"followers":2100},"tweet_id":"634457259200786432"},{"url":"http:\/\/twitter.com\/ConcordeMedica\/statuses\/634516363197984771","license":"gnip","citation_ids":[4418322],"posted_on":"2015-08-21T00:04:24+00:00","author":{"name":"Dr Alex Concorde","url":"http:\/\/www.dralexconcorde.info\/#!health-and-medicine\/c224f","image":"https:\/\/pbs.twimg.com\/profile_images\/1248165228\/concorde_medica_cropped__normal.jpg","description":"Dr Alex is creator of a unique 21C Individual Medicine called 'CruX'! This New Paradigm precisely identifies & targets mind\/-body pathways causing unwellness.","id_on_source":"ConcordeMedica","tweeter_id":"250807966","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":3792},"tweet_id":"634516363197984771"},{"url":"http:\/\/twitter.com\/uhesllc\/statuses\/634635464775897088","license":"gnip","citation_ids":[4418322],"posted_on":"2015-08-21T07:57:40+00:00","author":{"name":"UHES","url":"http:\/\/www.uhes.co","image":"https:\/\/pbs.twimg.com\/profile_images\/1964025189\/UHES_Logo_normal.png","id_on_source":"uhesllc","tweeter_id":"281746130","geo":{"lt":42.12753,"ln":-87.82895,"country":"US"},"followers":28},"tweet_id":"634635464775897088"},{"url":"http:\/\/twitter.com\/HealthEconBot\/statuses\/634663116228427776","license":"gnip","citation_ids":[4418322],"posted_on":"2015-08-21T09:47:33+00:00","author":{"name":"HealthEconBot","url":"http:\/\/healtheconbot.wordpress.com","image":"https:\/\/pbs.twimg.com\/profile_images\/2633259384\/1a5f3e7665ed3a78e410c56e50392c40_normal.jpeg","description":"I am a bot. I tweet health economics news, articles and working papers\r\n#HealthEconNews\r\n#HealthEconJA\r\n#HealthEconWP","id_on_source":"HealthEconBot","tweeter_id":"837451189","geo":{"lt":null,"ln":null},"followers":489},"tweet_id":"634663116228427776"},{"url":"http:\/\/twitter.com\/mHealthReporter\/statuses\/634664440491868160","license":"gnip","rt":["HealthEconBot"],"citation_ids":[4418322],"posted_on":"2015-08-21T09:52:48+00:00","author":{"name":"mHealth Reporter","image":"https:\/\/pbs.twimg.com\/profile_images\/440492947432148992\/zS2PqfTM_normal.png","description":"Information on startling discoveries in mHealth by our reporters.","id_on_source":"mHealthReporter","tweeter_id":"2370479576","geo":{"lt":null,"ln":null},"followers":1576},"tweet_id":"634664440491868160"},{"url":"http:\/\/twitter.com\/MltplSclppr\/statuses\/635030674047524864","license":"gnip","citation_ids":[4418322],"posted_on":"2015-08-22T10:08:05+00:00","author":{"name":"MS Papers","image":"https:\/\/pbs.twimg.com\/profile_images\/599614030790008833\/7IuEjHC7_normal.jpg","id_on_source":"MltplSclppr","tweeter_id":"3262004991","geo":{"lt":null,"ln":null},"followers":212},"tweet_id":"635030674047524864"},{"url":"http:\/\/twitter.com\/zeneconomicss\/statuses\/635031812285198336","license":"gnip","citation_ids":[4418322],"posted_on":"2015-08-22T10:12:37+00:00","author":{"name":"zeneconomicss","image":"https:\/\/pbs.twimg.com\/profile_images\/2046940554\/scarlett-johansson-9_normal.jpg","description":"Zen Economics","id_on_source":"zeneconomicss","tweeter_id":"546521838","geo":{"lt":null,"ln":null},"followers":279},"tweet_id":"635031812285198336"}],"facebook":[{"title":"Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs? -...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=866972996691359&id=588931371162191","license":"public","citation_ids":[4418322],"posted_on":"2015-08-21T09:47:26+00:00","summary":"#HealthEconJA Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs?","author":{"name":"Healtheconbot","url":"https:\/\/www.facebook.com\/588931371162191","facebook_wall_name":"Healtheconbot","image":"https:\/\/graph.facebook.com\/588931371162191\/picture","id_on_source":"588931371162191"}}]}}